Ask Warren

Sanigen

188260 · KOSDAQ · ₩188260 · 세니젠

₩1,962▲ ₩16 (0.82%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩3.8B₩3.3B−₩4.9B₩4.1B₩8.6B₩7.7B−₩1.6B₩6.6B
Cost of sales₩2.9B₩2.5B−₩4.9B₩3.1B₩7.3B₩6.7B−₩1.8B₩5.8B
Gross profit₩908M₩849M−₩13M₩909M₩1.2B₩995M₩181M₩824M
Operating income−₩405M−₩872M−₩1.8B−₩908M−₩791M−₩891M−₩1.8B−₩1.1B
Net income₩753M−₩898M−₩4.9B−₩125M₩91M−₩904M−₩5.4B₩210M
Net income to shareholders₩753M−₩898M−₩4.9B−₩125M₩91M−₩904M−₩5.4B₩210M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩23B₩9.7B₩10B₩15B₩15B₩16B₩15B₩18B
Current assets₩19B₩5.3B₩6.2B₩11B₩11B₩12B₩9.9B₩13B
Cash and equivalents₩6.4B₩1.1B₩1.6B₩2B₩1.9B₩3.3B₩5.5B₩2.2B
Total liabilities₩12B₩8.1B₩7.6B₩7.1B₩6.4B₩6.8B₩6.4B₩6.3B
Current liabilities₩8.2B₩4.1B₩3.8B₩3B₩2.3B₩2.7B₩2.4B₩2.2B
Borrowings₩3.5B₩2.5B₩2.1B₩2.2B₩1.5B₩1.6B₩1.6B₩1.6B
Total equity₩11B₩1.6B₩2.5B₩7.5B₩8.4B₩9.2B₩8.2B₩11B
Shareholders' equity₩11B₩1.6B₩2.5B₩7.5B₩8.4B₩9.2B₩8.2B₩11B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩645M−₩845M−₩295M−₩620M−₩1.2B−₩2.1B−₩520M−₩1.5B
Free cash flow−₩645M−₩845M−₩295M−₩620M−₩1.2B−₩2.1B−₩520M−₩1.5B

Consolidated where available. Amounts in won.

Also known as: Sanigen / 세니젠 / 188260 / KRX:188260

Source: KRX statistical information